Address: Sint Lambertusstraat – 141 rue Saint Lambert
1200 Brussels
Belgium
Tel: +322 774 11 00
Web: http://www.businessdecision-lifesciences.com/
Business & Decision Life Sciences is the international consulting and services division of Business & Decision Group, an international consulting and data engineering company founded in 1992 and listed on the Eurolist C exchange. The Life Sciences Division specializes in the delivery of services and provision of solutions in the Life Sciences industry. With 20 years of experience, it supports its clients in the pharmaceutical, medical device, biotechnology, food and cosmetics industries.
Core skills include business and IT consulting and the provision of a range of specialist CRO services. Other services are focused on the specific needs of the Life Sciences industry and the Division also delivers a range of technology based applications and solutions tailored for the Life Sciences industry.
Business & Decision Life Science was founded back in 2007, although that department existed within the group’s structure long before that. Could you highlight the reasons why a special business…
Sabena Solomon, general manager of GSK Benelux, speaks about her first impressions of the Belgium market, having come from GSK Finland, and her initial priorities for leading the affiliate. Solomon…
Karel Van De Sompel, country manager of Pfizer in Belgium and Luxembourg and chairman of Pharma.be, highlights the key changes he sees in today’s pharma market which revolve around the…
Professor Stéphane De Wit, head of the Department of Infectious Diseases at St Pierre University Hospital outlines Belgium’s approach to tackling HIV treatment, how academia-industry collaboration is progressing in the…
In 2020 PharmaBoardroom sat down with several key stakeholders in Belgian pharma to discuss company strategy, the Belgian healthcare landscape at large, and the country’s role within the wider European…
Francis Arickx, country coordinator of Belgium for the Beneluxa Initiative, introduces the project and its mission to help shape a unified healthcare policy approach between its member countries through activities…
Ian Wilders of Spain-headquartered micro-immunotherapy specialist Labo’Life discusses the strategic importance of Belgium to the company as the country in which micro-immunotherapy was discovered and where regulation conducive to the…
Luc Van Gorp of the Christian Mutuality Health Insurance Fund, Belgium’s largest health insurance fund, explains the organisation’s role within the Belgian healthcare system, how increased consolidation in recent years…
Dirk Reyn of Flanders.bio highlights what the Flanders region has to offer the life sciences and biotech industries in terms of research infrastructure, funding opportunities, and inter-industry collaboration. In…
Anne-Laure Dreno, country president of AstraZeneca in Belgium, elaborates on the significant position Belgium and the local affiliate have for the group as a frontrunner in innovative areas such as…
Roxana Botea, country manager of ViiV Healthcare in Belgium and Luxembourg, shares her experience joining the organization after a long career experience with GSK and her priorities as a first-time…
Glenn Vaughan of the British Chamber of Commerce | EU & Belgium discusses the importance of the Belgium-UK relationship, the role of healthcare and the life sciences within that, and…
Romuald Gaudefroy, managing director of CAF-DCF, the Belgian subsidiary of the LFB Group, introduces the company which was integrated into LFB in 2016. Gaudefroy goes on to offer insights on…
See our Cookie Privacy Policy Here
